openPR Logo
Press release

Cytomegalovirus Assay Market Latest Report with Forecast 2017-2027

08-22-2018 06:21 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Cytomegalovirus Assay Market Latest Report with Forecast

Global Cytomegalovirus Assay Market: Snapshot

CMV diagnostics turn out to be exceptionally basic for immunocompromised people and pregnant ladies as well. Cytomegaloviruses are one of the main sources of mental hindrance in kids and viral diseases. A cytomegalovirus can cause asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy from his mom, which may show essential or intermittent disease. Hence, it require a proper analysis of essential contamination in the pregnant lady that can be founded on IgG and IgM eagerness assays, a standout amongst the most sensitive serological assays or other ordinary sub-atomic and virological techniques for infection discovery in blood.

Cytomegalovirus has a place with the herpes viridae family and is a twice as stranded as DNA virus. This infection chiefly causes asymptomatic diseases or some of the time causes mild influenza like indications; and later stays dormant all through life, which may relapse. Hence, this infection can stay as a long lasting partner for a few people and can be a quiet killer for the others. Cytomegalovirus (CMV) contamination is described by the improvement of such antibodies, which is caused because of the disease of the infection that stays in a person's body for the duration of his life.

Request Report Brochure at https://www.factmr.com/connectus/sample?flag=B&rep_id=571

Cytomegalovirus is a common virus which belong to same family as herpesvirus. Cytomegalovirus causes cold sores and chickenpox. Cytomegalovirus is spread through contact spread with someone who have cytomegalovirus. It can also passed through body fluids such as saliva, urine and blood. Cytomegalovirus can cause serious disease such as retinitis, colitis, pneumonia, hepatitis and encephalitis. People with weak immune system can cause severe symptoms which affect eyes, lungs liver. Newborn babies with cytomegalovirus can have brain, liver and growth problems. Hearing loss is caused with the babies having cytomegalovirus infection. Cytomegalovirus is be detected through culture (human fibroblast), PCR, antigen assays, serologies, and cytopathology. Many cytomegalovirus assay are used for the detection of CMV IgG antibodies such as enzyme-linked immunosorbent assay (ELISA), indirect hemagglutination, radioimmunoassay and anticomplement immunofluorescence. Among all enzyme-linked immunosorbent assays (ELISAs) is widely used and is based on crude viral preparations. Congenital CMV infection is been recognized as a leading cause of congenital infection and brain disease in children in U.S. About 20,000 to 40,000 infants are born each year in the U.S. with congenital CMV infection. Development and standardizing molecular diagnostic methods which will result in the availability of reliable, rapid, and simple methods for routine clinical use in near future. In addition, there is also growing interest in examining the feasibility of a cytomegalovirus screening program in conjunction with universal newborn hearing screening in newborn.  Rapid culture methods are more comparable sensitivity and specificity to the standard cell culture assays and the results are available within 24 to 36 hours of sample taken. Saliva PCR assays are currently being assessed as a useful screening method for CMV infection in newborns. CMV infection has led to the development of diagnostic procedures for the rapid identification of CMV disease and infants with congenital infection.

Cytomegalovirus Assay Market: Drivers and Restraints

Cytomegalovirus Assay Market is fueled owing to rise in prevalence of cytomegalovirus infection, growing awareness among population regarding herpes disease and technological advancement in the diagnosis of the cytomegalovirus. Moreover rise in the initiative taken by the government and development of healthcare infrastructure are anticipated to boost the cytomegalovirus assay market globally. Lack of awareness in developing and under developed countries and price sensitivity are the factor which hinder the growth of the cytomegalovirus assay market.

Visit For TOC at https://www.factmr.com/connectus/sample?flag=T&rep_id=571

Cytomegalovirus Assay Market: Segmentation

Tentatively, global cytomegalovirus assay market has been segmented on the basis of test type, application, end user and geography.

Based on test type, global cytomegalovirus assay market is segmented as below:

Serology
Cell culture
Antigenemia
Polymerase Chain Reaction Amplification
Immunohistochemistry
Nucleic acid sequence-based amplification (NASBA)
Hybrid capture assay
Based on application type, global cytomegalovirus assay market is segmented as below:

Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Others (Mouth Ulcers, Pharyngitis, etc.)
 Based on end user, global cytomegalovirus assay market is segmented as below:

Hospitals
Diagnostic Centers
Others
 Cytomegalovirus Assay Market : Overview

Increase in cytomegalovirus infection cases propel the growth of the assay market. Patients who have undergone transplantation, new born and premature infants have higher risk of cytomegalovirus infection. New and traditional technique will increase the market of the cytomegalovirus assay market globally. Among all the test type antigenemia assay contributed the largest share which depend on the use of monoclonal antibodies that detect the viral pp65 antigen. The immense pace of research and development activities due to the large presence of biotechnology companies and pharmaceutical are the key factors contributes to the increase in the global cytomegalovirus assay market. Favorable government policies aims at the development of industries such as pharmaceuticals and biotechnology boost the cytomegalovirus assay market globally.

Cytomegalovirus Assay Market: Regional Outlook

Geographically, Cytomegalovirus Assay Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold largest shares in the global market primarily due to growing incidence of Cytomegalovirus and innovations in diagnostic techniques. Asia pacific Cytomegalovirus assay market is anticipated to witness prominent growth during the forecast period owing to increased healthcare expenditure and repeated outbreaks of infectious diseases in developing countries such as India and China.

Cytomegalovirus Assay Market: Key Players

Some of the key players in the Cytomegalovirus Assay Market are Merck KGaA, Qiagen, Abcam plc, BioVision Inc, DiaSorin Molecular LLC, Norgen Biotek Corp. among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Report Analysis at https://www.factmr.com/report/571/cytomegalovirus-assay-market

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus Assay Market Latest Report with Forecast 2017-2027 here

News-ID: 1194865 • Views:

More Releases from Fact.MR

Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2034: Fact.MR Report
03-29-2024 | Health & Medicine
Fact.MR
Atrial Fibrillation Device Market to Attain US$ 24.76 Billion at 14.3% CAGR by 2 …
The global atrial fibrillation devices market (心房細動装置市場) size stands at a valuation of US$ 6.52 billion in 2024, with forecasts predicting a surge to US$ 24.76 billion by the conclusion of 2034. Sales of atrial fibrillation devices worldwide are expected to witness an impressive compound annual growth rate (CAGR) of 14.3% from 2024 to 2034. In recent years, the global healthcare landscape has witnessed a significant surge in the prevalence of
Canola Oil Market Rising at 3.6% CAGR to Reach US$ 625 Million by 2032
03-29-2024 | Food & Beverage
Fact.MR
Canola Oil Market Rising at 3.6% CAGR to Reach US$ 625 Million by 2032
The canola oil market is expected to grow at a compound annual growth rate (CAGR) of 3.6% through 2032, from an estimated value of US$ 415 million in 2022 to US$ 625 million by the end of 2032. By the end of 2032, Bunge, ADM, and Louis Dreyfus Company are projected to be the top three producers of canola oil, accounting for around 31% of the global market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆
Digital Experience Platform Market Size to Cross US$ 29.5 Billion at 10.2% CAGR by 2032
Digital Experience Platform Market Size to Cross US$ 29.5 Billion at 10.2% CAGR …
The market for digital experience platforms is expected to expand at a remarkable 10.2% CAGR. It is anticipated to increase from US$ 9.9 billion in 2021 to around US$ 29.5 billion by 2032. A deeper level of customer involvement has been achieved through the evolution of digital customer platform integration, which began with content management systems (CMSs) in the 1980s and web experience management (WEM) solutions in the 1990s. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲
Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by 2032
Fiber Optic Gyroscope Market to Hit US$ 1,760.9 Million with 6.2% CAGR Growth by …
The fiber optic gyroscopes market is still expanding due to the need for dependable equipment for military and aerospace applications. With a compound annual growth rate (CAGR) of 6.2%, the global fiber optic gyroscope market is projected to reach a valuation of US$ 968.2 million in 2022 and US$ 1,760.9 million by the end of 2032. The market for fiber optic gyroscopes is anticipated to grow as a result of the

All 5 Releases


More Releases for Cytomegalovirus

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Cytomegalovirus Diagnostics Market to Record Ascending Growth by 2020
Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to
Global Cytomegalovirus Retinitis Market Size, Share | MarketResearchReports.biz
Latest industry research report on: Global Cytomegalovirus Retinitis Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions include floaters, flashes, and blind spots besides
Human Papillomavirus and Cytomegalovirus Therapeutics Market Analysis & Trends 2 …
A report by Transparency Market Research forecasts the global human papillomavirus (HPV) therapeutics market to rise at a CAGR of 7.7% during the period between 2014 and 2020 to become worth US$2.34 bn by 2020 from US$1.40 bn in 2012. According to the report, the global cytomegalovirus (CMV) market will rise at a 1.49 % CAGR from 2014 to 2020 to attain a value of US$922.8 mn by 2020 from
Human Papillomavirus and Cytomegalovirus Therapeutics Market Growth Analysis 202 …
Some of the prominent names in The Global Human Papillomavirus (HPV) And Cytomegalovirus (CMV) Therapeutics Market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market. A report by Transparency Market Research forecasts the global human papillomavirus
Global Cytomegalovirus Therapeutics Market Size, Status and Forecast 2022
This report studies the global Cytomegalovirus Therapeutics market, analyzes and researches the Cytomegalovirus Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like AbbVie Actavis Clinigen Group Merck Perrigo Company Roche Valeant Pharmaceuticals Sample of this report is available upon request @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1299282&type=E Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Cytomegalovirus Therapeutics can be split into Ganciclovir/Valganciclovir Foscarnet Cidofovir Market segment by